Predictive Factors of Development of Graves’ Ophthalmopathy for Patients with Juvenile Graves’ Disease

Table 1

General and disease characteristics of study sample ().

Variable	GO(–) ()		GO(+) ()		value
	Mean SD	Median (IQR)	Mean SD	Median (IQR)
Age, years	23 (6.0)	24 (17–28)	22 (7.0)	23 (16–28)	0.468
Gender
Female, % ()	91.3 (84)		76.3 (29)		0.021
Male, % ()	8.7 (8)		23.7 (9)
Ethnicity
Caucasian, % ()	100 (130)
BMI, kg/m^2	20.68 (19.15–22.33)		20.76 (19.17–22.09)		0.938
Duration of GD, months	72 (8–122)
Treatment, % ()
ATD MMI/PTU	54.6 (71)/4.6 (6)		22.3 (29)/2.3 (3)		0.916/0.720
Thyroidectomy	11.5 (15)		4.6 (6)		0.942
Radioactive iodine	2.3 (3)		1.5 (2)		0.589

GO (−): Graves’ disease patients without Graves’ ophthalmopathy; GO (+): Graves’ disease patients with Graves’ ophthalmopathy; BMI: body mass index; ATD: antithyroid drug; MMI: methimazole; PTU: propylthiouracil.